| Previous close | 2.3300 |
| Open | 2.3300 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 430.00 |
| Expiry date | 2025-12-19 |
| Day's range | 2.3300 - 2.3300 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksRegeneron Gains 13.5% Year to date: How to Play the Stock?
REGN maintains momentum as Eylea HD gains traction and Dupixent maintains momentum, even as lead drug Eylea faces challenges.
Insider MonkeyIs Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) The Best Morgan Stanley Overweight & Quality Stock?
We recently made a list of Morgan Stanley’s Best Overweight & Quality Stocks: Top 25 Stocks. In this piece, we will look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) ranks on the list of the top overweight and quality stocks. The close of September has cemented the paradigm shift on Wall Street. With the Federal Reserve’s […]
Insider MonkeyRegeneron Pharmaceuticals, Inc. (REGN): A Buzzing AI Health Stock to Add to Your Portfolio
We recently compiled a list of the 10 Buzzing AI Health Stocks. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against the other buzzing AI health stocks. The economic impact of AI is projected to be substantial, particularly in regions like China and North America, which are […]
